GSK3B and type 2 diabetes mellitus: INSR activation inhibits GSK3β [127] but, during IR and T2DM, GSK3β is not inhibited, and its activation stimulates the production of IL-1B, IL-6 and interferon (IFN)ɣ, reducing the production of anti-inflammatory cytokines [128].